IL-11, secreted from the bone-specific metastatic breast cancer cell line (BoM-1833), promotes osteolytic bone metastasis by activating RANKL-independent osteoclastogenesis through the JAK1/STAT3 pathway [52]. This evidence concerns the gene STAT3 and breast cancer.